Launch ACE-II & FGFR-3
We are pleased to inform you that our latest product developments are now available on request. You can find further information here.
Update TS-HDS
From now on we can determine the level of TS-HDS autoantibodies in your blood in our laboratory. For this purpose we need serum as for all other offered determinations. Information on blood sampling can be found here lab service
DetailsExtended antibody measurement
The CellTrend laboratory now offers an extended panel for antibody determination. request form advanced antibody measurement 2020 Autoimmune dysautonomia – Tel-Aviv – Shoenfeld – Review
Detailsswedish study on CFS/ME
Prof. Dr. Jonas Bergquist, University of Uppsala, Sweden, investigated antibodies against adrenergic receptors (a1, a2, b1, b2, b3) and acetylcholine muscarinergic receptors (M1-5) in two Swedish CFS/ME cohorts. For M3R-Ab and M4R-Ab a significant increase in antibody levels was found in CFS/ME patients compared to controls in both cohorts, for b1-adr-R-Ab and b2-adr-R-Ab only in…
DetailsCellTrend is a member of the “Network for Pharma Solutions”
The nationwide “Network for Pharma Solutions” (NetPhaSol), consists of 50 competent partners. The 20 research institutions and 30 companies including CellTrend are covering the entire value chain in drug discovery and development. The “Network for Pharma Solutions” (NetPhaSol) starts campaign for networking and cooperation Are you looking for qualified partner for your project? Are…
DetailsCan silicone breast implants trigger autoimmune diseases?
Can silicone breast implants trigger autoimmune diseases? Since the introduction of silicone breast implants in 1962 breast augmentation is the most common cosmetic surgery. But until today there were a lot of studies made which deal with the impairment of health and higher rates of several autoimmune diseases after silicone implants insertion. The condition is…
DetailsMonitoring audit for ISO 13485 passed
CellTrend passed the monitoring audit for ISO 13485! Our management system fulfills the required standards for development and production of immunologic assays, cell culture systems and in-vitro-diagnostics again!
New Research Article about HPV Vaccine and POTS/ CRPS
Human papillomavirus (HPV) infection promotes uterine and cervical cancers. In 2010, HPV vaccines were introduced worldwide. Since then case series of suspected adverse effects after HPV vaccination have been reported from several countries and the symptoms described by independent researchers are similar. In this study, autoantibodies against diverse Gprotein coupled receptors in the serum of…
Details1st Meeting at Charité Fatigue Center in Berlin on Nov 21/22 2019
The first Meeting on Chronic Fatigue in Immune-mediated disorders takes place in November 21/22 2019 in Berlin! Renowned scientists speak about the topics clinical presentation, diagnostic tools, pathomechanism and the treatment of Fatigue. Read more about it here!
DetailsNew study in JAHA about POTS published
New study in Journal of American Heart Association about POTS published: Postural Orthostatic Tachycardia Syndrome Is Associated With Elevated G‐Protein Coupled Receptor Autoantibodies. William T. GunningIII , Heather Kvale , Paula M. Kramer , Beverly L. Karabin , and Blair P. Grubb The aim of this study was to detect both the presence and prevalence…
Details